News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardiacAssist, Inc. Partners with Mentice Inc. to Showcase Transseptal Puncture Training Simulation at “TCT 2009” Exhibit Booth #2005


9/17/2009 2:18:36 PM

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist Inc. announced today that it will showcase transseptal puncture training simulation, developed by Mentice Inc., at its TandemHeart® System exhibit in San Francisco at the “Transcatheter Therapeutics (TCT) 2009” Annual Scientific Session next week. TandemHeart is the only 5 lpm net flow, percutaneous "extracorporeal circulatory support" device approved by the FDA for sale in the U.S. The TandemHeart device can be placed rapidly in a cath lab or an operating room—providing effective, reliable, temporary circulatory support for critically ill patients. TandemHeart is fully reimbursed by Medicare under existing DRG codes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES